Search Results 31-40 of 18112 for alzheimers
The Alzheimer's Disease Research Center studies the entire spectrum of aging, from normal aging to mild cognitive impairment to dementia in cooperation with the ...
Plaques are a characteristic sign of Alzheimer's disease. Strategies aimed at beta-amyloid include: Recruiting the immune system. Medicines known as monoclonal ...
The Food and Drug Administration (FDA) granted traditional approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's ...
Departments that treat this condition · Alzheimer's Disease Treatment Clinic · Behavioral Neurology · Neurology · Physical Medicine and Rehabilitation · Psychiatry ...
... Alzheimer's disease. Amyloid, the other toxic protein that characterizes Alzheimer's, builds up as dementia progresses, but is not the primary culprit, they ...
Lecanemab (Leqembi) is a medicine given to slow the progression of mild Alzheimer's disease (AD). This medicine reduces clumps of proteins called amyloid ...
Previously, Alzheimer's disease dementia was characterized by symptoms such as memory loss and changes in thinking and cognition. And that's still the case when ...
These symptoms may affect people with Alzheimer's disease and other types of dementia. The exact cause of sundowning is not known.
Is it worth finding out whether a patient who has some memory issues has Alzheimer's or dementia? ... Alzheimer's disease and dementia or slow cognitive decline.
When the SPRINT study intervention was stopped in September of 2015, important data on long term rate of Alzheimer's, change in cognition, and impact on the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.